Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative study on the mutation spectrum of tissue DNA and blood ctDNA in patients with non-small cell lung cancer. | Transl Cancer Res | 2022 | 35706796 | PubTator, text mining | PubMed |
| Modeling Brain Tumors: A Perspective Overview of in vivo and Organoid Models. | Front Mol Neurosci | 2022 | 35706426 | PubTator, text mining | PubMed |
| The Hippo pathway drives the cellular response to hydrostatic pressure. | EMBO J | 2022 | 35702882 | PubTator, text mining | PubMed |
| The interplay between noncoding RNA and YAP/TAZ signaling in cancers: molecular functions and mechanisms. | J Exp Clin Cancer Res | 2022 | 35701841 | PubTator, text mining | PubMed |
| Circadian effects on UV-induced damage and mutations. | Mutat Res Rev Mutat Res | 2022 | 35690416 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Screening membraneless organelle participants with machine-learning models that integrate multimodal features. | Proc Natl Acad Sci U S A | 2022 | 35687670 | PubTator, text mining | PubMed |
| Vitamin B6 Deficiency Promotes Loss of Heterozygosity (LOH) at the Drosophila warts (wts) Locus | Int J Mol Sci | 2022 | 35682766 | PubTator, text mining | PubMed |
| The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights. | Biochim Biophys Acta Rev Cancer | 2022 | 35680099 | PubTator, text mining | PubMed |
| Overview of Three Proliferation Pathways (Wnt, Notch, and Hippo) in Intestine and Immune System and Their Role in Inflammatory Bowel Diseases (IBDs). | Front Med (Lausanne) | 2022 | 35677821 | PubTator, text mining | PubMed |
| Diosgenin: An Updated Pharmacological Review and Therapeutic Perspectives. | Oxid Med Cell Longev | 2022 | 35677108 | PubTator, text mining | PubMed |
| The role of YAP1 in liver cancer stem cells: proven and potential mechanisms. | Biomark Res | 2022 | 35672802 | PubTator, text mining | PubMed |
| Longitudinal genomic alternations and clonal dynamics analysis of primary malignant melanoma of the esophagus. | Neoplasia | 2022 | 35661532 | PubTator, text mining | PubMed |
| Leveraging Bulk and Single-Cell RNA Sequencing Data of NSCLC Tumor Microenvironment and Therapeutic Potential of NLOC-15A, A Novel Multi-Target Small Molecule. | Front Immunol | 2022 | 35655775 | PubTator, text mining | PubMed |
| The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease. | J Exp Clin Cancer Res | 2022 | 35655220 | PubTator, text mining | PubMed |
| The Role of Feedback Loops in Targeted Therapy for Pancreatic Cancer. | Front Oncol | 2022 | 35651786 | PubTator, text mining | PubMed |
| Analysis of PANoptosis-Related LncRNA-miRNA-mRNA Network Reveals LncRNA SNHG7 Involved in Chemo-Resistance in Colon Adenocarcinoma. | Front Oncol | 2022 | 35646635 | PubTator, text mining | PubMed |
| Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1/LATS2/YAP1 signaling pathway in colorectal cancer. | Cancer Cell Int | 2022 | 35642057 | PubTator, text mining | PubMed |
| HERC3 directly targets RPL23A for ubiquitination degradation and further regulates Colorectal Cancer proliferation and the cell cycle. | Int J Biol Sci | 2022 | 35637966 | PubTator, text mining | PubMed |
| AURKA and PLK1 inhibition selectively and synergistically block cell cycle progression in diffuse midline glioma. | iScience | 2022 | 35637734 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=40